Epinephrine personal autoinjectors cost-effective at $24

(HealthDay)—In a simulation of children with peanut allergy, epinephrine personal autoinjectors are cost-effective at

Clementia Announces Plan to Submit a New Drug Application for Palovarotene for the Treatment of FOP Based on Positive Phase 2 Results

MONTREAL, Oct. 23, 2018 (GLOBE NEWSWIRE) — Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage

US health chief says overdose deaths beginning to level off

The number of U.S. drug overdose deaths has begun to level off after years

FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Asthma

PARIS and TARRYTOWN, N.Y., Oct. 19, 2018 /PRNewswire/ — Sanofi (EURONEXT: SAN) (NYSE: SNY)

Common use of antipsychotics shown ineffective for delirium in intensive care patients

Critically ill patients in intensive care units (ICUs) did not benefit from two antipsychotic

Prescription opioid and benzodiazepine misuse linked with suicidal thoughts

Misuse of prescription opioids or benzodiazepines (such as Xanax) was associated with suicidal ideation

Research assesses geographic distribution of new antibiotics following market introduction

There is a growing need for new antibiotics to help combat the looming threat

Despite crisis patients perceive opioids as superior and expect them for postsurgical pain

Even with concerns about addiction, side effects and the other risks of opioids dominating

Truvada for PrEP Prevents HIV, So Why Have Prescription Fills Dropped 30% Since 2015?

    Introduced in 2012, Truvada for PrEP (pre-exposure prophylaxis) is a mixture of

Oryzon Announces First Patient Enrolled in REIMAGINE: a Phase IIa Clinical Trial with Vafidemstat (ORY-2001) in Aggressiveness

MADRID, Spain and CAMBRIDGE, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) — Oryzon Genomics S.A.

Lilly’s Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes

INDIANAPOLIS, Oct. 4, 2018 /PRNewswire/ — Results from a phase 2b clinical trial of

Genentech Announces New Data for Risdiplam in Spinal Muscular Atrophy (SMA) at the World Muscle Society Congress

South San Francisco, CA — October 3, 2018 — Genentech, a member of the

Opioid-related hospital use up in elderly adults

(HealthDay)—Rates of opioid-related prescriptions and health care utilization are rising among seniors, according to

6 Doctor-Approved Tips For Cold And Flu Season

1. Zinc works 2. There’s nothing wrong with treating (some) symptoms 3. If you’re going use

Eisai Announces FDA Approval of Fycompa in Pediatric Patients as Young as 4 Years Old for the Treatment of Partial-Onset Seizures

WOODCLIFF LAKE, N.J., Sept. 28, 2018 /PRNewswire/ — Eisai Inc. announced today that the

Brexit will affect the UK’s ability to tackle illicit drugs trade, warn experts

Exclusion from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) because of

Genentech’s Investigational Medicine Entrectinib Showed a Durable Response of More Than Two Years in People With a Specific Type of Lung Cancer

South San Francisco, CA — September 24, 2018 — Genentech, a member of the

AbbVie Presents Upadacitinib Longer-Term (32-Week) and Patient-Reported Outcomes Data from Phase 2b Atopic Dermatitis Study at 27th European Academy of Dermatology and Venereology (EADV) Congress

NORTH CHICAGO, Ill., Sept. 13, 2018 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global

One in four older adults prescribed a benzodiazepine goes on to risky long-term use

They may start as well-intentioned efforts to calm anxiety, improve sleep or ease depression.

FDA Approves Imbruvica (ibrutinib) Plus Rituximab for Patients with Waldenström’s Macroglobulinemia

HORSHAM, Pa., August 27, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson

FDA warns of common diabetes meds’ link to dangerous genital infection

(HealthDay)—Rare but serious genital infections, as well as one death, have been reported in

Class-action suit takes aim at Big Pharma over babies exposed to opioids

A Philadelphia law firm has filed a proposed class-action lawsuit against a number of

New Illinois law allows medical marijuana pain prescriptions

Doctors in Illinois can now prescribe marijuana as a painkiller thanks to a new

Cantex Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CX-01 For The Treatment Of Patients Over Age 60 With Newly Diagnosed Acute Myeloid Leukemia (AML)

WESTON, Fla., Aug. 27, 2018 /PRNewswire/ — Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical

FDA Approves Oxervate

August 22, 2018 — The U.S. Food and Drug Administration today approved the first

How To Save on Insulin — With or Without Insurance Coverage

Steps for insured patients If you’re about to take insulin, choose one that’s preferred:

Are You Waiting for a Chantix Generic? Here’s How To Save on the Popular Smoking Cessation Drug

What is Chantix? Chantix is a popular, but expensive, prescription drug used for smoking

TG Therapeutics Announces Completion of Target Enrollment in the ULTIMATE Phase 3 Trials in Multiple Sclerosis

NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today

Cara Therapeutics Doses First Patient in Second Pivotal Phase 3 Efficacy Trial of Korsuva (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus

STAMFORD, Conn., Aug. 07, 2018 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical

FDA Approves Kalydeco (ivacaftor) for Cystic Fibrosis in Children Ages 12 to <24 Months with Certain Mutations in the CFTR Gene

BOSTON–(BUSINESS WIRE)–Aug. 15, 2018– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food